ArticleCancer immunology, immunotherapy : CII2019

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.

Laura A Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.